These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1380642)

  • 41. Autoantibodies in scleroderma and tightskin mice.
    Bona C; Rothfield N
    Curr Opin Immunol; 1994 Dec; 6(6):931-7. PubMed ID: 7710717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topoisomerases in human disease.
    McNeilage LJ; Whittingham S
    Lancet; 1988 Apr; 1(8589):822. PubMed ID: 2895336
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical significance of the anti-Sm antibody].
    Chen DL
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):13-5. PubMed ID: 3109698
    [No Abstract]   [Full Text] [Related]  

  • 44. Autoantigenic epitopes of the B and D polypeptides of the U1 snRNP. Analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera.
    Hirakata M; Craft J; Hardin JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3592-601. PubMed ID: 7682245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoantibodies--what do they recognize?
    Tan EM
    Verh Dtsch Ges Pathol; 1996; 80():1-11. PubMed ID: 9020568
    [No Abstract]   [Full Text] [Related]  

  • 46. [Role of determining the lymphocyte subpopulations in the clinical evaluation of scleroderma in children].
    Levina SG; Geppa NA; Uvarova NN; Snesarevskaia IP
    Pediatriia; 1980 Apr; (4):50-2. PubMed ID: 6966790
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens.
    McClain MT; Ramsland PA; Kaufman KM; James JA
    J Immunol; 2002 Feb; 168(4):2054-62. PubMed ID: 11823543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis.
    Hecker M; Lorenz P; Steinbeck F; Hong L; Riemekasten G; Li Y; Zettl UK; Thiesen HJ
    Autoimmun Rev; 2012 Jan; 11(3):180-90. PubMed ID: 21621003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Framework and CDR structures of anti-DNA antibodies are implicated in antigen binding.
    Ward FJ; Meshi B; Staines NA
    Biochem Soc Trans; 1997 May; 25(2):310S. PubMed ID: 9191354
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunochemical analysis of an arginine-rich systemic lupus erythematosus autoepitope.
    Pelsue S; Jung KD; Agris PF
    Autoimmunity; 1993; 15(3):231-6. PubMed ID: 7505633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis.
    Mahler M; Mierau R; Genth E; Blüthner M
    Arthritis Rheum; 2002 Jul; 46(7):1866-72. PubMed ID: 12124871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize multiple epitopes on the La(SS-B) autoantigen resembling viral protein sequences.
    Haaheim LR; Halse AK; Kvakestad R; Stern B; Normann O; Jonsson R
    Scand J Immunol; 1996 Jan; 43(1):115-21. PubMed ID: 8560190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells.
    Gershwin ME; Ansari AA; Mackay IR; Nakanuma Y; Nishio A; Rowley MJ; Coppel RL
    Immunol Rev; 2000 Apr; 174():210-25. PubMed ID: 10807518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells.
    Kuwana M; Medsger TA; Wright TM
    J Immunol; 2000 Jun; 164(12):6138-46. PubMed ID: 10843663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Scleroderma/polymyositis overlap syndromes and their immunologic markers.
    Jablonska S; Chorzelski TP; Blaszczyk M; Jarzabek-Chorzelska M; Kumar V; Beutner EH
    Clin Dermatol; 1992; 10(4):457-72. PubMed ID: 1303810
    [No Abstract]   [Full Text] [Related]  

  • 56. Autoantibodies in systemic sclerosis.
    Vázquez-Abad D; Rothfield NF
    Int Rev Immunol; 1995; 12(2-4):145-57. PubMed ID: 7650418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticentromere-A and anticentromere-B antibodies show high concordance and similar clinical associations in patients with systemic sclerosis.
    Hanke K; Becker MO; Brueckner CS; Meyer W; Janssen A; Schlumberger W; Hiepe F; Burmester GR; Riemekasten G
    J Rheumatol; 2010 Dec; 37(12):2548-52. PubMed ID: 20889593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Characteristics of cellular and humoral immunity in patients with systemic scleroderma].
    Iashchenko OB
    Vrach Delo; 1983 Feb; (2):61-4. PubMed ID: 6601883
    [No Abstract]   [Full Text] [Related]  

  • 59. Antigenicity of linear B-cell epitopes in the C1, V1, and V3 region of HIV-1 gp 120.
    van Tijn DA; Boucher CA; Bakker M; Goudsmit J
    J Acquir Immune Defic Syndr (1988); 1989; 2(3):303-6. PubMed ID: 2470894
    [No Abstract]   [Full Text] [Related]  

  • 60. Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRL lpr/lpr antibodies.
    James JA; Mamula MJ; Harley JB
    Clin Exp Immunol; 1994 Dec; 98(3):419-26. PubMed ID: 7527740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.